Business
Telix (ASX:TLX) share price down 4% despite new deal
Biopharma Telix Pharmaceuticals Ltd (ASX: TLX) share price is trading lower this morning, despite the company announcing the completion of its acquisition of Swiss-based company, TheraPharm.
At the same time, the company also announced that TheraPharm has now completed an intellectual property (IP) agreement with the University of Southampton in the United Kingdom.
At the time of writing, the Telix share price is trading at $3.59, down 4.27%.
About the TheraPharm acquisition
Telix advised it has now acquired all of the issued capital of TheraPharm for the final upfront consideration of €10.2 million (A$16.5 million). This was done at a price of $3.75 per share. That deal was first announced in late November.
Telix also…
-
General20 hours agoThreat from Stieglitz bushfire near St Helens on Tasmania’s east coast eases
-
General14 hours agoQueensland Police investigate death at Townsville’s Riverway Lagoon
-
Noosa News21 hours agoMurray River water thieves hit with $558,000 fine
-
Noosa News19 hours agoPolice road blitz | Noosa Today